​

Rockwell Medical (RMTI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RMTI Stock Forecast

Rockwell Medical (RMTI) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $20.00 and a low of $20.00. This represents a 180.11% increase from the last price of $7.14.

- $4 $8 $12 $16 $20 High: $20 Avg: $20 Low: $20 Last Closed Price: $7.14

RMTI Stock Rating

Rockwell Medical stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (62.50%), 2 Hold (12.50%), 4 Sell (25.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 4 2 10 Strong Sell Sell Hold Buy Strong Buy

RMTI Price Target Upside V Benchmarks

TypeNameUpside
StockRockwell Medical180.11%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks28.69%

Price Target Trends

1M3M12M
# Anlaysts-22
Avg Price Target-$11.00$11.00
Last Closing Price$7.14$7.14$7.14
Upside/Downside-54.06%54.06%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 2611---2
Jul, 2611---2
Jun, 2611---2
May, 2611---2
Apr, 2611---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 09, 2026H.C. Wainwright$20.00$5.63255.24%180.11%
May 22, 2026Raghuram SelvarajuH.C. Wainwright$2.00$0.81146.91%-71.99%
Mar 24, 2025Raghuram SelvarajuH.C. Wainwright$3.00$1.26138.10%-57.98%
Sep 04, 2024Raghuram SelvarajuH.C. Wainwright$9.00$3.19182.13%26.05%
Jul 17, 2023Raghuram SelvarajuH.C. Wainwright$11.00$4.19162.53%54.06%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 09, 2026H.C. WainwrightBuyBuyhold
May 22, 2026H.C. WainwrightBuyBuyhold
Mar 24, 2025H.C. WainwrightBuyBuyhold
Sep 04, 2024H.C. WainwrightBuyBuyhold
Jul 17, 2023H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.83$-1.89$-0.36$-0.03$-0.15---
Avg Forecast$-3.74$-2.12$-0.40$0.01$-0.09$-0.07$-0.03$0.06
High Forecast$-3.70$-2.06$-0.39$0.01$-0.09$-0.07$-0.03$0.06
Low Forecast$-3.78$-2.18$-0.41$0.01$-0.09$-0.07$-0.03$0.06
Surprise %2.41%-10.85%-10.00%-400.00%66.67%---

Revenue Forecast

$0 $14B $28B $42B $56B $70B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$61.93M$72.81M$83.61M$101.49M$69.26B---
Avg Forecast$64.25M$69.80M$84.15M$100.32M$77.13M$76.83M$69.40M$74.90M
High Forecast$64.72M$71.21M$86.34M$102.93M$79.13M$78.83M$71.20M$76.85M
Low Forecast$63.78M$68.39M$81.97M$97.71M$75.12M$74.83M$67.60M$72.95M
Surprise %-3.61%4.31%-0.64%1.17%89698.12%---

Net Income Forecast

$-6B $-4B $-3B $-2B $-700M $500M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-32.67M$-18.68M$-8.44M$-480.00K$-5.31B---
Avg Forecast$-87.23M$-62.32M$-8.59M$233.23K$-2.10M$-1.63M$-699.69K$1.40M
High Forecast$-86.40M$-49.86M$-6.87M$241.11K$-2.03M$-1.58M$-676.04K$1.45M
Low Forecast$-88.06M$-74.79M$-10.31M$225.35K$-2.17M$-1.69M$-723.33K$1.35M
Surprise %-62.54%-70.03%-1.75%-305.81%253060.76%---

RMTI Forecast FAQ

Is Rockwell Medical stock a buy?

Rockwell Medical stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that Rockwell Medical is a favorable investment for most analysts.

What is Rockwell Medical's price target?

Rockwell Medical's price target, set by 16 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $20 at the low end to $20 at the high end, suggesting a potential 180.11% change from the previous closing price of $7.14.

How does Rockwell Medical stock forecast compare to its benchmarks?

Rockwell Medical's stock forecast shows a 180.11% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the specialty & generic drug manufacturers stocks industry (28.69%).

What is the breakdown of analyst ratings for Rockwell Medical over the past three months?

  • August 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Rockwell Medical’s EPS forecast?

Rockwell Medical's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.07, marking a -53.33% decrease from the reported $-0.15 in 2025. Estimates for the following years are $-0.03 in 2027, and $0.06 in 2028.

What is Rockwell Medical’s revenue forecast?

Rockwell Medical's average annual revenue forecast for its fiscal year ending in December 2026 is $76.83M, reflecting a -99.89% decrease from the reported $69.26B in 2025. The forecast for 2027 is $69.4M, and $74.9M for 2028.

What is Rockwell Medical’s net income forecast?

Rockwell Medical's net income forecast for the fiscal year ending in December 2026 stands at $-1.633M, representing a -99.97% decrease from the reported $-5.314B in 2025. Projections indicate $-700K in 2027, and $1.4M in 2028.